Related Experiment Video
Updated: May 7, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Ergotamine-induced acute tubulo-interstitial nephritis
Maryam Pakfetrat1, Akbar Rasekhi, Fatemeh Eftekhari
1Shiraz NephroUrology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Ergotamine tartrate, a common migraine treatment, can cause severe hypertension and renal failure. A young woman developed acute tubulo-interstitial nephritis after using this medication.
Area of Science:
- Nephrology
- Pharmacology
- Internal Medicine
Background:
- Ergotamine tartrate is a widely used medication for migraine treatment in adults.
- Its safety and efficacy profile in adult migraineurs is generally well-established.
Observation:
- A 22-year-old female migraine patient was admitted with severe hypertension and acute renal failure.
- The patient had been undergoing treatment with ergotamine tartrate.
Findings:
- Renal biopsy revealed characteristic features of acute tubulo-interstitial nephritis.
- These findings suggest a direct link between ergotamine tartrate use and the observed kidney injury.
Implications:
- This case highlights a rare but serious adverse effect of ergotamine tartrate, necessitating careful patient monitoring.
- Clinicians should consider ergotamine tartrate-induced nephrotoxicity in patients presenting with unexplained renal failure and hypertension.
- Further research into the mechanisms of ergotamine-induced kidney damage may inform safer prescribing practices.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Pyelonephritis I: Introduction
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care
